Cristiano, A. et al. 2022. The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Apr. 2022), e2022041. DOI:https://doi.org/10.4084/MJHID.2022.041.